AlbusC. Health literacy: Is it important for cardiovascular disease prevention?Eur J Prev Cardiol2018; 25(9): 934–935.
2.
SørensenKPelikanJMRöthlinF, et al.for the HLS-EU Consortium. Health literacy in Europe: Comparative results of the European health literacy survey (HLS-EU). Eur J Public Health2015; 25: 1053–1058.
3.
Gorostegi-AnduagaICorresPMartinez Aguirre-BetolazaA, et al.Effects of different aerobic exercise programmes with nutritional intervention in sedentary adults with overweight/obesity and hypertension: EXERDIET-HTA study. Eur J Prev Cardiol2018; 25: 343–353.
4.
RochaVZSantosRD. Cholesterol and inflammation: The lesser the better in atherothrombosis. Eur J Prev Cardiol2018; 25: 944–947.
5.
TuñónJBäckMBadimónL, et al.Interplay between hypercholesterolaemia and inflammation in atherosclerosis: Translating experimental targets into clinical practice. Eur J Prev Cardiol2018; 25(9): 948–955.
6.
ZieglerLGajulapuriAFrumentoP, et al.Interleukin 6 trans-signalling and risk of future cardiovascular events. Cardiovasc Res2019; 115: 213–221.
7.
CuchelMBruckertEGinsbergHN, et al.Homozygous familial hypercholesterolaemia: New insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society. Eur Heart J2014; 35: 2146–2157.
8.
D’ErasmoLCefaluABNotoD, et al.Efficacy of lomitapide in the treatment of familial homozygous hypercholesterolemia: Results of a real-world clinical experience in Italy. Adv Ther2017; 34: 1200–1210.
9.
LachmanSBoekholdtSMLubenRN, et al.Impact of physical activity on the risk of cardiovascular disease in middle-aged and older adults: EPIC Norfolk prospective population study. Eur J Prev Cardiol2018; 25: 200–208.
